American International Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-20,601
| Closed | -$989K | – | 3256 |
|
2020
Q1 | $989K | Sell |
20,601
-1,192
| -5% | -$57.2K | 0.01% | 1113 |
|
2019
Q4 | $1.02M | Sell |
21,793
-182
| -0.8% | -$8.54K | ﹤0.01% | 1320 |
|
2019
Q3 | $520K | Buy |
21,975
+2,064
| +10% | +$48.8K | ﹤0.01% | 1633 |
|
2019
Q2 | $599K | Buy |
19,911
+7,919
| +66% | +$238K | ﹤0.01% | 1600 |
|
2019
Q1 | $269K | Buy |
11,992
+2,481
| +26% | +$55.7K | ﹤0.01% | 2046 |
|
2018
Q4 | $173K | Sell |
9,511
-73
| -0.8% | -$1.33K | ﹤0.01% | 2267 |
|
2018
Q3 | $173K | Buy |
9,584
+174
| +2% | +$3.14K | ﹤0.01% | 2522 |
|
2018
Q2 | $94K | Sell |
9,410
-922
| -9% | -$9.21K | ﹤0.01% | 2821 |
|
2018
Q1 | $55K | Buy |
10,332
+2,413
| +30% | +$12.8K | ﹤0.01% | 2883 |
|
2017
Q4 | $67K | Buy |
7,919
+38
| +0.5% | +$322 | ﹤0.01% | 2882 |
|
2017
Q3 | $115K | Buy |
7,881
+589
| +8% | +$8.6K | ﹤0.01% | 2597 |
|
2017
Q2 | $137K | Buy |
7,292
+2,478
| +51% | +$46.6K | ﹤0.01% | 2519 |
|
2017
Q1 | $102K | Buy |
+4,814
| New | +$102K | ﹤0.01% | 2581 |
|